{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T16:40:17Z","timestamp":1723826417918},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00210-024-02991-2","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T09:03:25Z","timestamp":1708074205000},"page":"5927-5937","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Regulation of I1-imidazoline receptors on the sedation effect of dexmedetomidine in mice"],"prefix":"10.1007","volume":"397","author":[{"given":"Xiao","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-fang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai-yun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guan-yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"key":"2991_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ejphar.2011.05.043","volume":"666","author":"A Bahremand","year":"2011","unstructured":"Bahremand A, Ziai P, Payandemehr B, Rahimian R, Amouzegar A, Khezrian M, Montaser-Kouhsari L, Meibodi MA, Ebrahimi A, Ghasemi A, Ghasemi M, Dehpour AR (2011) Additive anticonvulsant effects of agmatine and lithium chloride on pentylenetetrazole-induced clonic seizure in mice: involvement of alpha(2)-adrenoceptor. Eur J Pharmacol 666:93\u201399. https:\/\/doi.org\/10.1016\/j.ejphar.2011.05.043","journal-title":"Eur J Pharmacol"},{"key":"2991_CR2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.pharep.2016.03.008","volume":"68","author":"K Boblewski","year":"2016","unstructured":"Boblewski K, Lehmann A, Saczewski F, Saczewski J, Kornicka A, Marchwinska A, Rybczynska A (2016) Circulatory effect of TCS-80, a new imidazoline compound, in rats. Pharmacol Rep 68:715\u2013719. https:\/\/doi.org\/10.1016\/j.pharep.2016.03.008","journal-title":"Pharmacol Rep"},{"key":"2991_CR3","first-page":"232","volume":"230","author":"P Bousquet","year":"1984","unstructured":"Bousquet P, Feldman J, Schwartz J (1984) Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J Pharmacol Exp Ther 230:232\u2013236","journal-title":"J Pharmacol Exp Ther"},{"key":"2991_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1196\/annals.1304.057","volume":"1009","author":"MJ Chen","year":"2003","unstructured":"Chen MJ, Zhu HE, Piletz JE (2003) Intracellular effect of imidazoline receptor on alpha(2A)-noradrenergic receptor. Ann N Y Acad Sci 1009:427\u2013438. https:\/\/doi.org\/10.1196\/annals.1304.057","journal-title":"Ann N Y Acad Sci"},{"key":"2991_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0024-3205(94)00415-o","volume":"56","author":"EE Codd","year":"1995","unstructured":"Codd EE, Press JB, Raffa RB (1995) Alpha 2-adrenoceptors vs. imidazoline receptors: implications for alpha 2-mediated analgesia and other non-cardiovascular therapeutic uses. Life Sci 56:63\u201374. https:\/\/doi.org\/10.1016\/0024-3205(94)00415-o","journal-title":"Life Sci"},{"key":"2991_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/ALN.0b013e318164ca81","volume":"108","author":"S Dahmani","year":"2008","unstructured":"Dahmani S, Paris A, Jannier V, Hein L, Rouelle D, Scholz J, Gressens P, Mantz J (2008) Dexmedetomidine increases hippocampal phosphorylated extracellular signal-regulated protein kinase 1 and 2 content by an alpha 2-adrenoceptor-independent mechanism: evidence for the involvement of imidazoline I1 receptors. Anesthesiology 108:457\u2013466. https:\/\/doi.org\/10.1097\/ALN.0b013e318164ca81","journal-title":"Anesthesiology"},{"key":"2991_CR7","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/sj.cdd.4401275","volume":"10","author":"M Dontenwill","year":"2003","unstructured":"Dontenwill M, Pascal G, Piletz JE, Chen M, Baldwin J, Ronde P, Dupuy L, Urosevic D, Greney H, Takeda K, Bousquet P (2003) IRAS, the human homologue of nischarin, prolongs survival of transfected PC12 cells. Cell Death Differ 10:933\u2013935. https:\/\/doi.org\/10.1038\/sj.cdd.4401275","journal-title":"Cell Death Differ"},{"key":"2991_CR8","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.ejphar.2016.10.009","volume":"791","author":"RB Ferreira","year":"2016","unstructured":"Ferreira RB, de Oliveira MG, Antunes E, Almeida WP, Ibrahim BM, Abdel-Rahman AA (2016) New 2-aminothiazoline derivatives lower blood pressure of spontaneously hypertensive rats (SHR) via I1-imidazoline and alpha-2 adrenergic receptors activation. Eur J Pharmacol 791:803\u2013810. https:\/\/doi.org\/10.1016\/j.ejphar.2016.10.009","journal-title":"Eur J Pharmacol"},{"key":"2991_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s0197-0186(96)00040-x","volume":"30","author":"A Flamez","year":"1997","unstructured":"Flamez A, De Backer JP, Czerwiec E, Ladure P, Vauquelin G (1997) Pharmacological characterization of I1 and I2 imidazoline receptors in human striatum. Neurochem Int 30:25\u201329. https:\/\/doi.org\/10.1016\/s0197-0186(96)00040-x","journal-title":"Neurochem Int"},{"key":"2991_CR10","doi-asserted-by":"publisher","first-page":"PL 41","DOI":"10.1016\/0024-3205(95)02274-0","volume":"58","author":"GM Gilad","year":"1996","unstructured":"Gilad GM, Salame K, Rabey JM, Gilad VH (1996) Agmatine treatment is neuroprotective in rodent brain injury models. Life Sci 58:PL 41-46. https:\/\/doi.org\/10.1016\/0024-3205(95)02274-0","journal-title":"Life Sci"},{"key":"2991_CR11","first-page":"1142","volume":"57","author":"H Greney","year":"2000","unstructured":"Greney H, Ronde P, Magnier C, Maranca F, Rascente C, Quaglia W, Giannella M, Pigini M, Brasili L, Lugnier C, Bousquet P, Dontenwill M (2000) Coupling of I(1) imidazoline receptors to the cAMP pathway: studies with a highly selective ligand, benazoline. Mol Pharmacol 57:1142\u20131151","journal-title":"Mol Pharmacol"},{"key":"2991_CR12","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1097\/ALN.0b013e3182700ab9","volume":"117","author":"FY Hu","year":"2012","unstructured":"Hu FY, Hanna GM, Han W, Mardini F, Thomas SA, Wyner AJ, Kelz MB (2012) Hypnotic hypersensitivity to volatile anesthetics and dexmedetomidine in dopamine beta-hydroxylase knockout mice. Anesthesiology 117:1006\u20131017. https:\/\/doi.org\/10.1097\/ALN.0b013e3182700ab9","journal-title":"Anesthesiology"},{"key":"2991_CR13","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/sj.bjp.0701520","volume":"122","author":"JC Hunter","year":"1997","unstructured":"Hunter JC, Fontana DJ, Hedley LR, Jasper JR, Lewis R, Link RE, Secchi R, Sutton J, Eglen RM (1997) Assessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. Br J Pharmacol 122:1339\u20131344. https:\/\/doi.org\/10.1038\/sj.bjp.0701520","journal-title":"Br J Pharmacol"},{"key":"2991_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1399-6576.2007.01537.x","volume":"52","author":"E Huupponen","year":"2008","unstructured":"Huupponen E, Maksimow A, Lapinlampi P, Sarkela M, Saastamoinen A, Snapir A, Scheinin H, Scheinin M, Merilainen P, Himanen SL, Jaaskelainen S (2008) Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleep. Acta Anaesthesiol Scand 52:289\u2013294. https:\/\/doi.org\/10.1111\/j.1399-6576.2007.01537.x","journal-title":"Acta Anaesthesiol Scand"},{"key":"2991_CR15","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1097\/00000542-199710000-00032","volume":"87","author":"K Kagawa","year":"1997","unstructured":"Kagawa K, Mammoto T, Hayashi Y, Kamibayashi T, Mashimo T, Yoshiya I (1997) The effect of imidazoline receptors and alpha2-adrenoceptors on the anesthetic requirement (MAC) for halothane in rats. Anesthesiology 87:963\u2013967. https:\/\/doi.org\/10.1097\/00000542-199710000-00032","journal-title":"Anesthesiology"},{"key":"2991_CR16","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1097\/00000542-199511000-00022","volume":"83","author":"T Kamibayashi","year":"1995","unstructured":"Kamibayashi T, Mammoto T, Hayashi Y, Yamatodani A, Takada K, Sasaki S, Yoshiya I (1995) Further characterization of the receptor mechanism involved in the antidysrhythmic effect of dexmedetomidine on halothane\/epinephrine dysrhythmias in dogs. Anesthesiology 83:1082\u20131089. https:\/\/doi.org\/10.1097\/00000542-199511000-00022","journal-title":"Anesthesiology"},{"key":"2991_CR17","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1126\/science.7906055","volume":"263","author":"G Li","year":"1994","unstructured":"Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJ (1994) Agmatine: an endogenous clonidine-displacing substance in the brain. Science 263:966\u2013969. https:\/\/doi.org\/10.1126\/science.7906055","journal-title":"Science"},{"key":"2991_CR18","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/jcb.20806","volume":"98","author":"F Li","year":"2006","unstructured":"Li F, Wu N, Su RB, Zheng JQ, Xu B, Lu XQ, Cong B, Li J (2006) Involvement of phosphatidylcholine-selective phospholipase C in activation of mitogen-activated protein kinase pathways in imidazoline receptor antisera-selected protein. J Cell Biochem 98:1615\u20131628. https:\/\/doi.org\/10.1002\/jcb.20806","journal-title":"J Cell Biochem"},{"key":"2991_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2011.08.019","volume":"1427","author":"L Liu","year":"2012","unstructured":"Liu L, Ji F, Liang J, He H, Fu Y, Cao M (2012) Inhibition by dexmedetomidine of the activation of spinal dorsal horn glias and the intracellular ERK signaling pathway induced by nerve injury. Brain Res 1427:1\u20139. https:\/\/doi.org\/10.1016\/j.brainres.2011.08.019","journal-title":"Brain Res"},{"key":"2991_CR20","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1097\/ALN.0000000000001236","volume":"125","author":"A Lodenius","year":"2016","unstructured":"Lodenius A, Ebberyd A, Hardemark Cedborg A, Hagel E, Mkrtchian S, Christensson E, Ullman J, Scheinin M, Eriksson LI, Jonsson Fagerlund M (2016) Sedation with dexmedetomidine or propofol impairs hypoxic control of breathing in healthy male volunteers: a nonblinded, randomized crossover study. Anesthesiology 125:700\u2013715. https:\/\/doi.org\/10.1097\/ALN.0000000000001236","journal-title":"Anesthesiology"},{"key":"2991_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.yjmcc.2013.12.030","volume":"68","author":"AV Maltsev","year":"2014","unstructured":"Maltsev AV, Kokoz YM, Evdokimovskii EV, Pimenov OY, Reyes S, Alekseev AE (2014) Alpha-2 adrenoceptors and imidazoline receptors in cardiomyocytes mediate counterbalancing effect of agmatine on NO synthesis and intracellular calcium handling. J Mol Cell Cardiol 68:66\u201374. https:\/\/doi.org\/10.1016\/j.yjmcc.2013.12.030","journal-title":"J Mol Cell Cardiol"},{"key":"2991_CR22","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/sj.bjp.0702679","volume":"127","author":"G Olmos","year":"1999","unstructured":"Olmos G, DeGregorio-Rocasolano N, Paz Regalado M, Gasull T, Assumpcio Boronat M, Trullas R, Villarroel A, Lerma J, Garcia-Sevilla JA (1999) Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Br J Pharmacol 127:1317\u20131326. https:\/\/doi.org\/10.1038\/sj.bjp.0702679","journal-title":"Br J Pharmacol"},{"key":"2991_CR23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1089\/10445490050043290","volume":"19","author":"JE Piletz","year":"2000","unstructured":"Piletz JE, Ivanov TR, Sharp JD, Ernsberger P, Chang CH, Pickard RT, Gold G, Roth B, Zhu H, Jones JC, Baldwin J, Reis DJ (2000) Imidazoline receptor antisera-selected (IRAS) cDNA: cloning and characterization. DNA Cell Biol 19:319\u2013329. https:\/\/doi.org\/10.1089\/10445490050043290","journal-title":"DNA Cell Biol"},{"key":"2991_CR24","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1196\/annals.1304.053","volume":"1009","author":"JE Piletz","year":"2003","unstructured":"Piletz JE, Wang G, Zhu H (2003) Cell signaling by imidazoline-1 receptor candidate, IRAS, and the nischarin homologue. Ann N Y Acad Sci 1009:392\u2013399. https:\/\/doi.org\/10.1196\/annals.1304.053","journal-title":"Ann N Y Acad Sci"},{"key":"2991_CR25","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1080\/01616412.2019.1672391","volume":"41","author":"Y Qian","year":"2019","unstructured":"Qian Y, Wang Q, Jiao J, Wang G, Gu Z, Huang D, Wang Z (2019) Intrathecal injection of dexmedetomidine ameliorates chronic neuropathic pain via the modulation of MPK3\/ERK1\/2 in a mouse model of chronic neuropathic pain. Neurol Res 41:1059\u20131068. https:\/\/doi.org\/10.1080\/01616412.2019.1672391","journal-title":"Neurol Res"},{"key":"2991_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s11064-019-02922-1","volume":"45","author":"Z Qiu","year":"2020","unstructured":"Qiu Z, Lu P, Wang K, Zhao X, Li Q, Wen J, Zhang H, Li R, Wei H, Lv Y, Zhang S, Zhang P (2020) Dexmedetomidine inhibits neuroinflammation by altering microglial M1\/M2 polarization through MAPK\/ERK pathway. Neurochem Res 45:345\u2013353. https:\/\/doi.org\/10.1007\/s11064-019-02922-1","journal-title":"Neurochem Res"},{"key":"2991_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1196\/annals.1304.002","volume":"1009","author":"S Regunathan","year":"2003","unstructured":"Regunathan S, Piletz JE (2003) Regulation of inducible nitric oxide synthase and agmatine synthesis in macrophages and astrocytes. Ann N Y Acad Sci 1009:20\u201329. https:\/\/doi.org\/10.1196\/annals.1304.002","journal-title":"Ann N Y Acad Sci"},{"key":"2991_CR28","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0014-2999(96)00224-5","volume":"306","author":"MK Savola","year":"1996","unstructured":"Savola MK, Savola JM (1996) [3H]dexmedetomidine, an alpha 2-adrenoceptor agonist, detects a novel imidazole binding site in adult rat spinal cord. Eur J Pharmacol 306:315\u2013323. https:\/\/doi.org\/10.1016\/0014-2999(96)00224-5","journal-title":"Eur J Pharmacol"},{"key":"2991_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2377-12-20","volume":"12","author":"M Schoeler","year":"2012","unstructured":"Schoeler M, Loetscher PD, Rossaint R, Fahlenkamp AV, Eberhardt G, Rex S, Weis J, Coburn M (2012) Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury. BMC Neurol 12:20. https:\/\/doi.org\/10.1186\/1471-2377-12-20","journal-title":"BMC Neurol"},{"key":"2991_CR30","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.neubiorev.2011.08.006","volume":"36","author":"TI Uzbay","year":"2012","unstructured":"Uzbay TI (2012) The pharmacological importance of agmatine in the brain. Neurosci Biobehav Rev 36:502\u2013519. https:\/\/doi.org\/10.1016\/j.neubiorev.2011.08.006","journal-title":"Neurosci Biobehav Rev"},{"key":"2991_CR31","doi-asserted-by":"publisher","first-page":"E95","DOI":"10.1152\/ajpendo.00021.2015","volume":"309","author":"M Weiss","year":"2015","unstructured":"Weiss M, Bouchoucha S, Aiad F, Ayme-Dietrich E, Dali-Youcef N, Bousquet P, Greney H, Niederhoffer N (2015) Imidazoline-like drugs improve insulin sensitivity through peripheral stimulation of adiponectin and AMPK pathways in a rat model of glucose intolerance. Am J Physiol Endocrinol Metab 309:E95-104. https:\/\/doi.org\/10.1152\/ajpendo.00021.2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2991_CR32","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.2174\/1570159X15666170808120633","volume":"16","author":"W Xu","year":"2018","unstructured":"Xu W, Gao L, Li T, Shao A, Zhang J (2018) Neuroprotective role of agmatine in neurological diseases. Curr Neuropharmacol 16:1296\u20131305. https:\/\/doi.org\/10.2174\/1570159X15666170808120633","journal-title":"Curr Neuropharmacol"},{"key":"2991_CR33","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1016\/j.febslet.2006.04.058","volume":"580","author":"J Zhang","year":"2006","unstructured":"Zhang J, Abdel-Rahman AA (2006) Nischarin as a functional imidazoline (I1) receptor. FEBS Lett 580:3070\u20133074. https:\/\/doi.org\/10.1016\/j.febslet.2006.04.058","journal-title":"FEBS Lett"},{"key":"2991_CR34","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1124\/jpet.107.129049","volume":"324","author":"J Zhang","year":"2008","unstructured":"Zhang J, Abdel-Rahman AA (2008) Inhibition of nischarin expression attenuates rilmenidine-evoked hypotension and phosphorylated extracellular signal-regulated kinase 1\/2 production in the rostral ventrolateral medulla of rats. J Pharmacol Exp Ther 324:72\u201378. https:\/\/doi.org\/10.1124\/jpet.107.129049","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-02991-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-02991-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-02991-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T16:06:29Z","timestamp":1723824389000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-02991-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["2991"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-02991-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"type":"print","value":"0028-1298"},{"type":"electronic","value":"1432-1912"}],"subject":[],"published":{"date-parts":[[2024,2,16]]},"assertion":[{"value":"19 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were carried out in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 8023, revised 1978). All experiments involving animals were approved by the local ethical committee and the Institutional Review Committee on Animal Care (IACUC-2021-017W).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}